SFCL
LXRX icon

Strengthening Families & Communities LLC’s Lexicon Pharmaceuticals LXRX Stock Holding History

Strengthening Families & Communities LLC’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1
Closed – – 390
2022
Q4 		$0 Buy
+1
New +$2 ﹤0.01% 362

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Strengthening Families & Communities LLC's LXRX Position: Q1 2023 in Review

Strengthening Families & Communities LLC sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2023, closing a stake of 1 share.

Strengthening Families & Communities LLC first reported a position in LXRX in Q4 2022 and held it in 1 quarter. The position peaked at $0 in Q4 2022. 104 funds tracked by Wall St. Rank hold LXRX as of Q1 2023.

  • Strengthening Families & Communities LLC reported no remaining Lexicon Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Strengthening Families & Communities LLC sold 1 Lexicon Pharmaceuticals share in Q1 2023.
  • Strengthening Families & Communities LLC first reported a position in Lexicon Pharmaceuticals in Q4 2022 and held it in 1 quarter.
  • Strengthening Families & Communities LLC's Lexicon Pharmaceuticals position peaked at $0 in Q4 2022.
  • 104 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2023.

Based on Strengthening Families & Communities LLC's 13F filing for Q1 2023, filed 4 May 2023.